Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 17CNS 9Lymphoid 8Head & Neck 8Gastrointestinal 7Other hematologic neoplasm 6Gynecologic 6Thoracic 5Breast 5Dermatologic 4Other solid neoplasm 2Tumor-Agnostic 1Sarcoma 1Plasma cell 1Other neoplasm 1NET 1Endocrine 1

Conditions

Retinoblastoma 1Hematopoietic and Lymphoid System Neoplasm 1

Interventions

pembrolizumab 75Injections 67Carboplatin 38Pemetrexed 29Cisplatin 29Nivolumab 27Specimen Handling 24Interviews as Topic 24Cyclophosphamide 24atezolizumab 21tislelizumab 20Bevacizumab 20Paclitaxel 19Standard of Care 16Practice Guidelines as Topic 16fludarabine 15Docetaxel 15toripalimab 14Ipilimumab 14Educational Status 14Cetuximab 14Fluorouracil 13Oxaliplatin 12Etoposide 12olaparib 11durvalumab 11Methods 11Gemcitabine 11Early Intervention, Educational 11Drug Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Watchful Waiting × Other solid neoplasm × 1 year × Clear all
NCT05873608 2026-04-06

Communication Issues in Patient and Provider Discussions of Immunotherapy

Emory University

Phase NA Recruiting
125 enrolled
Other solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

NCT04425434 2026-03-02

GFARB12019

French Africa Pediatric Oncology Group

Recruiting
3,000 enrolled
Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡